ClinicalTrials.gov
ClinicalTrials.gov Menu

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (APPLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01220050
Recruitment Status : Completed
First Posted : October 13, 2010
Last Update Posted : February 22, 2013
Sponsor:
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : February 2013